IMARC Group, a leading market research company, has recently releases report titled “Blood Plasma Derivatives Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028.” The study provides a detailed analysis of the industry, including the global blood plasma derivatives market share, size, trends, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.

How Big is the Blood Plasma Derivatives Market?

The global blood plasma derivatives market size reached US$ 43.2 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 61.9 Billion by 2028, exhibiting a growth rate (CAGR) of 6.1% during 2023-2028.

What are Blood Plasma Derivatives?

Blood plasma derivatives are concentrated fractions of plasma proteins that are obtained from human donors and separated using fractionation processes. They contain different proteins, including antibodies, clotting factors, and albumin, and are used to create a variety of therapeutic products. They are also employed to treat rare diseases and conditions that have no other effective treatment options. They are also utilized to prevent infections, improve quality of life and boost the immune system in patients with immunodeficiency disorders.

Request Free Sample Copy of This Report: https://www.imarcgroup.com/blood-plasma-derivatives-market/requestsample

What are the growth prospects and trends in the blood plasma derivatives industry?

The growing geriatric population, increasing prevalence of medical disorders, and rising awareness about rare diseases among people are among the key factors positively influencing the market. In addition, the burgeoning healthcare sector and the development of new and improved blood plasma derivatives with better efficacy and safety profiles are fueling the market growth.

Apart from this, the growing support in the development and commercialization of blood plasma derivatives is creating a favorable market outlook. Additionally, sedentary lifestyles, low immunity levels, and increasing infections are propelling the demand for blood plasma derivatives for treatments, which is contributing to the market growth.

Moreover, the development of advanced preservation methods and significant investments in research and development (R&D) activities for developing therapeutic and preventive agents are stimulating the growth of the market worldwide.

What is included in market segmentation?

The report has segmented the market into the following categories:

Breakup by Type:

• Albumin

• Factor VIII

• Factor IX

• Immunoglobulin

• Hyperimmune Globulin

• Others

Breakup by Application:

• Hemophilia

• Hypogammaglobulinemia

• Immunodeficiency Diseases

• Von Willebrand's Disease

• Others

Breakup by End User:

• Hospitals

• Clinics

• Others

Market Breakup by Region:

• North America (United States, Canada)

• Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)

• Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)

• Latin America (Brazil, Mexico, Others)

• Middle East and Africa

Who are the key players operating in the industry?

The report covers the major market players including: 

Baxter International Inc., Bayer AG, CSL Limited, Fusion Health Care Pvt. Ltd., Grifols S.A., Kedrion S.p.A., LFB S.A., Octapharma AG, Sanofi S.A. and Takeda Pharmaceutical Company Limited.

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC Group’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact US

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

USA: +1-631-791-1145 | Asia: +91-120-433-0800

Email: sales@imarcgroup.com

Follow us on Twitter: @imarcglobal

LinkedIn: https://www.linkedin.com/company/imarc-group/mycompany/